TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: “Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial”